ICU Medical (NASDAQ:ICUI) Upgraded to Buy at StockNews.com

StockNews.com upgraded shares of ICU Medical (NASDAQ:ICUI) from a hold rating to a buy rating in a report published on Friday morning.

Other equities research analysts have also recently issued research reports about the company. Jefferies Financial Group upgraded ICU Medical from a “hold” rating to a “buy” rating and set a $200.00 price objective for the company in a report on Wednesday, December 11th. Raymond James set a $97.00 target price on shares of ICU Medical in a research report on Wednesday, March 12th. One investment analyst has rated the stock with a hold rating, three have issued a buy rating and one has assigned a strong buy rating to the company’s stock. According to data from MarketBeat.com, the company currently has an average rating of “Buy” and a consensus target price of $168.67.

ICU Medical Price Performance

NASDAQ:ICUI opened at $139.32 on Friday. ICU Medical has a one year low of $93.36 and a one year high of $196.26. The company has a market cap of $3.42 billion, a P/E ratio of -30.49 and a beta of 0.86. The firm’s fifty day moving average price is $151.64 and its two-hundred day moving average price is $162.46. The company has a debt-to-equity ratio of 0.75, a current ratio of 2.29 and a quick ratio of 1.03.

Hedge Funds Weigh In On ICU Medical

Hedge funds have recently added to or reduced their stakes in the stock. Arizona State Retirement System raised its position in ICU Medical by 1.0% during the fourth quarter. Arizona State Retirement System now owns 6,730 shares of the medical instruments supplier’s stock valued at $1,044,000 after purchasing an additional 65 shares in the last quarter. Huntington National Bank raised its position in ICU Medical by 6.2% in the fourth quarter. Huntington National Bank now owns 1,402 shares of the medical instruments supplier’s stock valued at $218,000 after purchasing an additional 82 shares during the last quarter. Equitable Trust Co. raised its holdings in ICU Medical by 1.6% in the 4th quarter. Equitable Trust Co. now owns 5,297 shares of the medical instruments supplier’s stock valued at $822,000 after buying an additional 84 shares during the last quarter. LPL Financial LLC increased its position in ICU Medical by 2.0% in the 4th quarter. LPL Financial LLC now owns 4,816 shares of the medical instruments supplier’s stock valued at $747,000 after acquiring an additional 93 shares during the period. Finally, Alliancebernstein L.P. raised its stake in shares of ICU Medical by 0.5% during the fourth quarter. Alliancebernstein L.P. now owns 26,107 shares of the medical instruments supplier’s stock valued at $4,051,000 after acquiring an additional 136 shares during the last quarter. Institutional investors own 96.10% of the company’s stock.

ICU Medical Company Profile

ICU Medical, Inc, together with its subsidiaries, develops, manufactures, and sells medical devices used in infusion therapy, vascular access, and vital care applications worldwide. Its infusion therapy products include needlefree products under the MicroClave, MicroClave Clear, and NanoClave brands; Neutron catheter patency devices; ChemoClave and ChemoLock closed system transfer devices, which are used to limit the escape of hazardous drugs or vapor concentrations, block the transfer of environmental contaminants into the system, and eliminates the risk of needlestick injury; Tego needle free connectors; Deltec GRIPPER non-coring needles for portal access; and ClearGuard, SwabCap, and SwabTip disinfection caps.